Charles Schwab Investment Management Inc Horizon Therapeutics Public LTD CO Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$98.98 - $115.74 $934,074 - $1.09 Million	-9,437 Reduced 1.0%	935,067 $108 Million
Q2 2023 Aug 09, 2023	BUY	$96.34 - $112.38 $1.35 Million - $1.57 Million	13,977 Added 1.5%	944,504 $97.1 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $2.25 Million - $2.38 Million	20,930 Added 2.3%	930,527 $102 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $1.81 Million - $3.3 Million	-29,002 Reduced 3.09%	909,597 $104 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $2.33 Million - $3.34 Million	39,471 Added 4.39%	938,599 $58.1 Million

Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $8.95 Million - $13.1 Million	112,731 Added 14.34%	899,128 $71.7 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $797,483 - $1.01 Million	9,228 Added 1.19%	786,397 $82.7 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $756,152 - $919,949	7,672 Added 1.0%	777,169 $83.7 Million
Q3 2021 Nov 16, 2021	SELL	$91.91 - $110.37 $2.01 Million - $2.41 Million	-21,834 Reduced 2.76%	769,497 $84.3 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $955,194 - $1.06 Million	11,076 Added 1.42%	791,331 $74.1 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $383,715 - $510,054	5,342 Added 0.69%	780,255 $71.8 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $715,158 - $900,778	-10,674 Reduced 1.36%	774,913 $56.7 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $43.9 Million - $63.6 Million	-795,486 Reduced 50.31%	785,587 $61 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $544,596 - $1.03 Million	-18,033 Reduced 1.13%	1,581,073 $87.9 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $1.14 Million - $1.77 Million	-45,982 Reduced 2.8%	1,599,106 $47.4 Million
Q4 2019 Feb 07, 2020	BUY	$25.43 - $36.67 $1.35 Million - $1.94 Million	53,012 Added 3.33%	1,645,088 $59.6 Million
Q3 2019 Nov 08, 2019	BUY	$23.0 - $27.97 $10.3 Million - $12.5 Million	446,246 Added 38.95%	1,592,076 $43.4 Million
Q2 2019 Aug 09, 2019	BUY	$22.81 - $28.48 $26.1 Million - $32.6 Million	1,145,830 New	1,145,830 $27.6 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account